BBP (Virtus Biotech ETF) Stock Analysis - Financials

Virtus Biotech ETF (BBP) is a publicly traded the market company. As of May 21, 2026, BBP trades at $90.21 with a market cap of $0 and a P/E ratio of 0.00. BBP moved +3.43% today. Year to date, BBP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BBP's key financials?

BBP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBP recently traded at $90.21. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

BBP Key Metrics

Key financial metrics for BBP
MetricValue
Price$90.21
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume140.02K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BBP News

BBP Analyst Consensus

BBP analyst coverage data. Average price target: $0.00.

Common questions about BBP

What are BBP's key financials?
BBP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBP recently traded at $90.21. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is BBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBP. It does not provide personalized investment advice.
BBP

BBP